Clinical Trials for Alkeus Pharmaceuticals

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Alkeus Pharmaceuticals

Clinical Trials (2)

NCT04239625
Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)
PHASE2Active, not recruiting
200 participants
Started: Dec 20, 2019 · Completed: Dec 31, 2026
4 conditions1 sponsor8 locations
NCT02402660
Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease
PHASE2Enrolling by invitation
160 participants
Started: Aug 31, 2015 · Completed: Nov 30, 2026
4 conditions1 sponsor14 locations